Acetylshikonin Inhibits Human Pancreatic PANC-1 Cancer Cell Proliferation by Suppressing the NF-κB Activity
Acetylshikonin, a natural naphthoquinone derivative compound, has been used for treatment of inflammation and cancer. In the present study, we have investigated whether acetylshikonin could regulate the NF-κB signaling pathway, thereby leading to suppression of tumorigenesis. We observed that acetyl...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Society of Applied Pharmacology
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556202/ |